Research. Discover. Cure.

This groundbreaking test helps oncologists determine which breast cancer patients should be treated with bisphosphonates to improve their prognosis and survival.

The jury highlighted Dr. López-Bigas’s "innovative research on the origin and evolution of cancer mutations and the development of tools to study them."

The conference gathered 150 international researchers to explore the potential of artificial intelligence (AI) to transform Biomedicine and Drug Discovery.

Visit the memorial webpage and share your memories to acknowledge this exceptional man.

The IRB Barcelona researcher is awarded €2 M to undertake the IGNITE Project over the next five years.